Valuation: Acarix AB

Market Cap 299M 30.84M 27.02M 24.99M 22.97M 43.41M 2.97B 44.09M 117M 1.46B 116M 113M 5.05B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 299M 30.84M 27.02M 24.99M 22.97M 43.41M 2.97B 44.09M 117M 1.46B 116M 113M 5.05B EV / Sales 2026 *
15.6x
EV / Sales 2027 * 4.3x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-0.20%
1 week-0.98%
Current month-1.18%
1 month+1.00%
3 months-16.17%
6 months-1.57%
Current year-6.16%
1 week 0.25
Extreme 0.246
0.26
1 month 0.24
Extreme 0.2435
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.45
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.87
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 52 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-0.98%-39.03%-52.00% 31.05M
-2.47%-1.90%+15.75%-25.65% 17.27B
+1.64%-5.48%+0.79%+91.39% 1.57B
-4.60%-9.25%-34.85%-80.19% 1.19B
+1.29%-4.72%-37.01%+15.19% 999M
-0.64%+2.18%-28.81%-52.65% 644M
-1.79%-5.76%-41.68%-57.20% 532M
+0.66%-3.89%+46.69%-53.85% 445M
0.00%+0.64%-54.33%-58.66% 382M
+1.09%+7.51%-18.78%-22.74% 364M
Average -0.50%-1.69%-19.13%-29.64% 2.34B
Weighted average by Cap. -1.92%-0.35%+6.24%-21.36%

Financials

2026 *2027 *
Net sales 19.1M 1.97M 1.73M 1.6M 1.47M 2.78M 190M 2.82M 7.48M 93.05M 7.4M 7.24M 323M 69.5M 7.18M 6.29M 5.81M 5.35M 10.1M 692M 10.26M 27.23M 339M 26.94M 26.35M 1.18B
Net income -28.9M -2.98M -2.61M -2.42M -2.22M -4.2M -288M -4.27M -11.32M -141M -11.2M -10.96M -489M 2.4M 248K 217K 201K 185K 349K 23.89M 354K 940K 11.69M 930K 910K 40.58M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
20/07/26 SEK 0.2515 -0.20% 269,697
17/07/26 SEK 0.2520 0.00% 1,038,030
16/07/26 SEK 0.2520 +1.20% 415,663
15/07/26 SEK 0.2490 -1.39% 350,191
14/07/26 SEK 0.2525 -0.39% 32,706

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock